Science Premium

Is indigenous vaccine trial possible until 15 August in India?

India has come at number three in the world in terms of corona infection. The only ray of hope among growing cases of infection is the formation of its vaccine. But the biggest question is when will the corona vaccine be made and when will it reach people?

First came a circular of the Indian Council of Medical Research, i.e. ICMR, on 2 July, stating that by 15 August, India would produce a vaccine called Biotech Covaxin.

The ICMR subsequently issued an explanation on this circular. The clarification stated that the circular was issued only because government files continued to move faster in the process.

But the matter did not end here. Now, an article of the Institute of Science Dissemination under the Ministry of Science and Technology of the Central Government has stirred again.

This article has been written by Dr. T.V. Venkateswaran, Head of Science Communication Training Department of Vigyan Prasar for the Information Bureau (PIB).

According to media reports, it was mentioned in the article that the corona vaccine cannot come before 2021. But in many media reports, it has been claimed that the 2021 line was removed from the website of PIB immediately and uploaded the article again.

In such a situation, questions are arising that why the government is looking in a hurry regarding the corona vaccine? And can the process of making a vaccine be announced properly beforehand?

According to media reports, the Science Dissemination article stated that 11 of the 140 vaccine companies worldwide, along with India's Covaxin and Zykov-D, are in the human trials phase, but in getting licenses for its use It will take 15 to 18 months.

Before this, none of these vaccines is likely to be ready for mass use.

However, later this article removed the line 'It will take 15 to 18 months to get a license for its use'.

Now this article states that the approval of the Controller General of India for the Covid-19 for testing Indian vaccines, Covaxin and Zykov-D on humans is the 'beginning of the end' of the Corona virus epidemic.

This article still exists on the website of the Information Bureau (PIB). It has also been claimed in the article that wherever Corona vaccine is made in the world, it is not possible to get it in the whole world without its production in India.

The article published on the PIB website no longer mentions the time limit for the vaccine.

On this whole controversy, BBC correspondent Saroj Singh contacted Doctor TV Venkateswara over phone.

He refused to comment on the entire controversy. In a phone conversation with the BBC, he said, "These are all policy issues." It will be better if only the right people comment on it. As far as I'm concerned. I am with the revised version published on PIB.

Dr. Randeep Guleria, director of AIIMS in Delhi, has also made it clear in an interview with a private news channel that the talk of indigenous vaccine trials by August 15 seems impractical.

He made it clear in the interview that the objective of the ICMR letter was that every institution should move towards doing their work faster.

AIIMS in Delhi is also going to have a trial of this indigenous vaccine made by Bharat Biotech.

On the other hand, Biocon India chairperson Kiran Mazumdar Shaw also wrote on Twitter, "It is impossible to complete Phase 1 to 3 trials for the Kovid-19 vaccine in 6 months."

BBC Telugu correspondent Deepti Bathini spoke to Suchitra Alla, managing director of Bharat Biotech, hours before ICMR's letter.

Suchitra Alla said, "One thousand people will be selected in the first phase of the human clinical trial." All international guidelines will be followed for this. The election of volunteers will also be closely monitored. Those from all over the country will be selected for trials which are Covid-free. It will take at least 30 days to know what the reaction was on those people.

He added, "We do not know whether the geographical conditions will also have an impact." That is why we have chosen people from all over India. We want to make sure that it has a good response. It will take 45 to 60 days to submit the data for the first phase.

After taking blood samples, the test cycle cannot be reduced. Test results will take 15 days to reach us.

In India, all efforts are being made to prepare the Covid-19 vaccine. But still a lot needs to be done in this direction.

After the vaccine is ready, the first task will be to find out how safe it is. If it were to cause more problems than the disease, then the vaccine would not be of any benefit.

In clinical trials, it will be seen whether the vaccine is able to develop resistance against Covid-19 so that people do not get caught after taking the vaccine.

Even after the vaccine is ready, billions of doses will need to be prepared. The vaccine will also need approval from drug regulatory agencies.

Even if all this happens, the big challenge will remain. Arrangements will also have to be made for logistic arrangements to deliver its food to billions of people around the world.

Is the indigenous vaccine the beginning of the end of the corona?

After allowing the human clinical trial of the indigenous vaccine Covaxin and ZyCov-D for the corona virus in India, the government said it was 'the beginning of the end of the corona'.

The Union Ministry of Science and Technology in India has said in its letter that more than 100 vaccines are being tested all over the world and only 11 of them are undergoing human trials.

"The human trials of the vaccine will begin after getting permission from the Drug Controller General of India, which is the beginning of an end," the ministry letter said.

Six Indian companies are working on the Kovid-19 vaccine. Out of 140 vaccines across the world, 11 are undergoing human trials including two Indian vaccines Covaxin and ZyCov-D.

Usually the first two stages of a drug test are about safety while the third phase is about the effect of the drug.

Each phase can take months to years to complete.

The letter from the ministry came at a time when there was a dispute over deciding the last date of release of the ICMR vaccine to 15 August.

However, ICMR has now made it clear that the vaccine will come on the market only on the basis of global regulations.

Among the two indigenous vaccines that have been allowed to undergo human trials in India are Covaxin of Bharat Biotech and ZyCov-D of Zaedus Cadila.

Permission for first and second phase testing was received this week.

Can women who have become mothers not donate plasma?

Plasma bank has recently been started in Delhi to deal with the corona epidemic. Plasma therapy was approved for treatment of corona virus patients. Now it is also being used in the treatment of patients with critical condition.

It is the first plasma bank in India to treat corona. It is built in the Bank Institute of Liver and Biliary Science (ILBC) Hospital. The plasma bank is expected to make it easier for patients to get plasma.

In such a situation, appeals are being made to donate the plasma to cured patients of Covid-19. However, not every corona virus patient can donate plasma. Some conditions have been laid for this.

It has been reported that she has become a mother anytime in her life and currently pregnant women cannot donate plasma.

ILBS director AK Sarin told in an interview to Hindustan Times, an English newspaper, that plasma cannot be taken from pregnant women and pregnant women. Their plasma can do more harm to the Covid-19 patient.

Why was the use of hydroxychloroquine and HIV medicine discontinued on corona-infected patients?

The World Health Organization said Saturday that hydroxychloroquine and lopinavir / ritonavir are being discontinued on corona-infected patients.

The hydroxychloroquine used to treat malaria and the lopinavir / ritonavir drug given to HIV patients did not succeed in preventing mortality of corona infectives, after which the decision has been taken.

The drug was seen as an expectation in different vaccine and medicine trials in search of treatment for corona and this bad news has come at a time when the World Health Organization itself has reported that for the first time worldwide More than two lakh corona infection cases have been reported in a single day.

On Friday, there were 212,326 reported cases of corona infection worldwide, with 53,213 cases reported in the US alone.

The World Health Organization said in a statement, "The results from the medical trial showed that the use of hydroxychloroquine and lopinavir / ritonavir reduced the mortality rate of hospitalized corona patients by little or no. Therefore, trial of these drugs will be stopped with immediate effect.

In different countries of the world, the effect of these drugs on corona patients under the leadership of the World Health Organization was being investigated.

The United Nations Health Agency said that the decision has been taken based on the recommendation of an international committee.

However, the WHO has clarified that patients who are not hospitalized and who use them as a preventive treatment will not be affected by this decision.